Last updated: March 30, 2026

Alcoholism

Alcohol is the most significant, most commonly used, and most commonly abused drug. Intoxication is measured with blood alcohol concentration (BAC). It is a depressant (contrary to popular belief that it is a stimulant, as it can ultimately cause respiratory depression). The WHO recommends no more than 14 units of alcohol per week.

Alcohol use disorder (WHO, 1952) is defined as a chronic disease characterised by a fundamental disturbance of the nervous system manifested on a behavioural level by a state of physical dependence. AUD is common in occupations with flexible work schedules and those that facilitate access to alcohol

  • How alcoholism manifests (WHO, 1952)
    • Inability to stop drinking before drunkenness is achieved
    • Inability to abstain from drinking because of the appearance of withdrawal
  • A major predisposing factor for alcohol use disorder:
    • Excessive alcohol use in first-degree relatives: there is a 30-60% concordance in monozygotic twins, confirmed by adoption studies done in Scandinavian countries
  • Screening tests for alcohol use disorder
    • CAGE Questionnaire: specific to alcohol. Answering 2 or more of these as “yes” means the patient is dependent on alcohol. Most sensitive screening test, with a sensitivity of 60-100%
    • Michigan alcoholism screening test (MAST): 13-item test, self-administered. Sensitivity 30-78%
    • AUDIT test: 10-question audit. Sensitivity 38-40%.
    • TWEAK test: tolerance, worried, eye-opener, amnesia, cut down. Sensitivity 79%
  • Pathophysiology
    • Chronic alcohol consumption enhances GABA-mediated inhibition in the CNS and inhibits NMDA-type glutamate receptors
  • Signs and symptoms of low levels of intoxication
    • Euphoria
    • Talkativity
  • Signs and symptoms of high levels of intoxication
    • Clumsiness
    • Emotional lability
    • Sedation
    • Nausea and vomiting
    • Anterograde amnesia (blackouts)
    • Confusion
    • Coma
    • Death
  • Treatment of alcohol intoxication
    • ABCs
    • Intravenous fluids with thiamine
    • Benzodiazepine, e.g., chlordiazepoxide and diazepam, on a scheduled basis to prevent Delirium Tremens
  • Treatment of dependence (long-term)
    • Alcoholics Anonymous (Group Psychotherapy)
    • Acamprosate: interferes with glutaminergic signalling to reduce craving
    • Naltrexone: antagonises endogenous endorphins to reduce craving
    • Disulfiram (antabuse): blocks the metabolism of alcohol via aldehyde dehydrogenase, causing acetaldehyde to accumulate. Hence, when the patient takes alcohol, they get flushing, palpitations and vomiting as a side effect.
  • Why is chlorpromazine (and antipsychotics in general) avoided in patients presenting with alcohol intoxication?

CAGE Questionnaire

CAGEQuestion
Cutting downDo you ever feel like you should Cut down on your drinking?
AngerDo you feel Anger when people confront you about your drinking?
GuiltDo you ever feel Guilty about your drinking?
Eye-openerHave you used alcohol as an Eye-opener after waking up?

Complications of Chronic Alcohol Use

Psychiatric complications of alcohol use

ComplicationDescription
Alcohol WithdrawalWithdrawal symptoms occur within 6-12 hours after the last drink and can lead to Delirium Tremens
Wernicke’s encephalopathyGliosis and haemorrhages in the limbic system, and structures around the 3rd ventricle and aqueduct due to thiamine deficiency
Korsakoff’s SyndromePermanent damage to structures in the limbic system leading to anterograde and retrograde amnesia
Alcoholic DementiaAssociated with white and grey matter loss
Cerebellar degenerationA very common complication that occurs as a result of the loss of Purkinje cells in the cerebellar cortex. Presents with dysarthria and limb ataxia
Alcoholic HallucinosisA rare complication, but very characteristic if present. It can be permanent if untreated. Presents with derogatory auditory hallucinations in the presence of a clear sensorium. The patient may be distressed – they are unpleasant and cause much anxiety. Treated with antipsychotics
Alcohol-induced depressive symptomsOccurs in 80% of alcohol dependence. 1/3 male and 1/2 female dependent patients experience it. 15% of alcoholics die by suicide.
Alcohol-induced anxiety disorderOccurs in 70% of heavy drinkers
Alcohol-induced Psychotic disorder (including Othello’s Syndrome)Common in alcoholics. Othello’s syndrome is delusions of infidelity (of jealousy) of a significant other. Very difficult to treat, and if attempts do not work, divorce is advised. It can lead to homicide.

Medical complications of alcohol use

SystemComplications
Central nervous systemAlcoholic Cerebellar Degeneration, Marchiafava Bignami Disease (demyelination/necrosis of the corpus callosum and related subcortical white matter in chronically ill-fed alcoholics due to B-vitamin deficiency), Central Pontine Myelinolysis, Traumatic brain injury
Gastrointestinal systemErosive gastritis, Peptic ulcer, Pancreatitis, Liver disease (Alcoholic steatosis, Alcoholic hepatitis, Alcoholic cirrhosis)
Cardiovascular systemHypertension, Cardiomyopathy, Arrhythmia, Congestive Heart Failure, Cerebrovascular accident
Genitourinary systemTesticular atrophy, Infertility, Miscarriage
Haemato-oncologyMacrocytic anemia, Cancer of the mouth and oral cavity, cancer of the oropharynx, cancer of the oesophagus
Fetal Alcohol Spectrum DisorderFacial Dysmorphisms (Microcephaly, thin upper lip, Down-slanting eyes, Hypertelorism, epicanthal folds, receding chin), Systemic features (VSD, Heart-lung fistulas, Skeletal anomalies, Renal-aplastic or dysplastic, Growth retardation), and Intellectual disability
Facial dysmorphism seen in fetal alcohol spectrum disorder
Marchiafava-Bignami disease. MRI Axial FLAIR shows T2 hyperintensity confined to the corpus callosum. Source: Dr Balaji Anveka FRCR
Marchiafava-Bignami disease. Restricted diffusion at the corpus callosum on diffusion weighted imaging. Source: Dr Balaji Anveka FRCR
Diffuse cerebellar atrophy

Alcohol Withdrawal

Alcohol withdrawal occurs within 6-12 hours after the last drink. Withdrawal symptoms are what drive people to continue drinking. It may not be a severe illness. Withdrawal can lead to Delirium Tremens (DTs), which has a mortality rate of 5-15%. Withdrawal should be managed acutely to prevent progression to Wernicke-Korsakoff (permanent brain damage and amnesia)

Alcohol withdrawal

Peak incidence (timeframe)Features
6 – 12 hoursWithdrawal symptoms
36 hoursSeizures
72 hoursDelirium tremens
  • Pathophysiology
    • In alcohol withdrawal, there is marked excitatory action mediated by the glutamatergic system (increased NMDA glutamate transmission) and decreased inhibitory GABA
  • Signs and symptoms of alcohol withdrawal
    • Tremor
    • Anxiety
    • Seizure or Hallucinations (characteristic of DTs)
    • Insomnia
    • Irritability
    • Anxiety
    • Tremors
    • Loss of appetite
    • Tinnitus
    • Sweating (perspiration)
  • Signs and symptoms of Delirium Tremens (DTs)
    • Disorientation in time and place (as a result of reduced level of consciousness)
    • Tremors (Marked)
    • Visual, tactile and auditory hallucinations or illusions (symptoms tend to be worse in the evening and better in the morning; “Creepy Crawlies”/ formication)
    • Sweating
    • Tachycardia
    • Hypertension
    • Dilated pupils
    • Ataxia
    • Anxious (very, very, very anxious)
    • Seizures (rum fits, less common – occurs in 5% of patients in withdrawal)
  • Treatment of Delirium Tremens
    • Admit (can be in the ICU)
    • Supportive care
    • Sedate the patient with a benzodiazepine, e.g. diazepam, lorazepam: no dose limit, give as much as is needed for sedation. Then taper.
    • Dextrose bolus with Thiamine containing vitamin complex: this is continued for 3 months
    • AVOID using antipsychotics (especially Chlorpormazine): may induce more fits
  • Complications of alcohol withdrawal
    • Post-withdrawal Wernicke’s encephalopathy
    • Korsakoff syndrome (an anamnestic state)

Wernicke’s encephalopathy

Wernicke’s encephalopathy is caused by thiamine deficiency, which causes gliosis and haemorrhages in structures around the 3rd ventricle and aqueduct. These structures include: mamillary bodies, hypothalamus, mediodorsal thalamic nuclei, colliculi, and mibdrain tegmentum. If not managed aggressively, 80% of patients progress to the amnestic stage (Korsakoff’s syndrome).

  • Functions of the Papez circuit
    • Important in memory and forgetting
    • Emotional control
  • Signs and symptoms
    • Global confusion (with extreme anxiety)
    • Memory deficits
    • Ataxia
    • Ocular signs (horizontal nystagmus, weakness of lateral rectus, and conjugate gaze paralysis)

Korsakoff’s Syndrome

Korsakoff’s syndrome may appear without antecedent Wernicke’s encephalopathy. It is caused by permanent damage to structures in the limbic system. Lesions are in the dorsomedial thalamus (on histology). Anterograde and retrograde memory loss

  • Signs and symptoms
    • Clear sensorium (MMSE)
    • Intact intellectual abilities – they develop confabulation since they are aware that they have memory deficits
    • Global amnesia
    • Confabulation: subconsciously fills gaps in memory (intellect is conserved)

Wernicke-Korsakoff

Structures affectedSymptoms
Wernicke’s (Acute)Cerebellum, Brainstem, Mamillary bodies, Thalamus, HypothalamusConfusion, Ophthalmoplegia, Ataxia, Loss of appetite, Autonomic dysfunction, Peripheral neuropathy
Korsakoff’s (Chronic)Papez circuit, CerebellumAmnesia, Confabulation, Behavioral Symptoms

Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *